Social Media Ideas for /Business/Csf-Testing

Blood tests are easier to order than ever. Doctors warn they're easy to misread.

  Blood work used to start with a doctor’s order, usually to diagnose or monitor disease. But people are increasingly using blood work to ask proactive questions like: How healthy...

Kuros Biosciences AG (CSBTF) Q2 2026 Earnings Call Transcript

What to expect from CSL shares this reporting season

Will CSL surprise or disappoint investors? The post What to expect from CSL shares this reporting season appeared first on The Motley Fool Australia.

Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test

Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.

Screening India’s healthcare diagnostics market

CSL shares: 1 number that investors shouldn't ignore

This one number has me rethinking a CSL investment. The post CSL shares: 1 number that investors shouldn't ignore appeared first on The Motley Fool Australia.

Buy, hold, sell: What is Bell Potter saying about CSL shares?

Bell Potter has been looking at the biotech giant ahead of its results release. The post Buy, hold, sell: What is Bell Potter saying about CSL shares? appeared first on The Motley...

Biomarker BS…OK it’s disappointing

Neurofilament assay is used as a marker of nerve damage or inflammation induced nerve damage/inflammatory activity, and the people doing these assays have been part of a biomarker...

Up 88%! Why CSL shares remain an 'appealing' buy today

A top analyst forecasts more outperformance from CSL’s surging shares. The post Up 88%! Why CSL shares remain an 'appealing' buy today appeared first on The Motley Fool Australia.

<![CDATA[Revitalizing recruitment in a lupus rescue study: A collaborative approach by Quest Diagnostics and Patients...

Function Just Raised $450 Million. Its CEO and Co-Founder Says It Has No Competitors

Direct-to-consumer lab testing is projected to hit $6.5 billion as more consumers demand preventive health data. Some experts are urging caution.

CSL shares rebound 86%: Is the ASX biotech stock a buy, sell or hold for September?

Find out why investors are now rushing to buy CSL shares. The post CSL shares rebound 86%: Is the ASX biotech stock a buy, sell or hold for September? appeared first on The Motley...

Charity Research Support Fund (CRSF)

Summary The medical research charity sector in the UK plays a vital role in the UK’s health and economy, filling in a niche often not covered by government and other funders...

Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup

Advanced Labs includes insights into cardiovascular, metabolic and inflammatory health through comprehensive, clinician-reviewed blood testing.

New $44M Las Vegas medical lab aims to keep testing in Nevada, cut wait times

The $44 million facility near UNLV’s medical school will expand in-state diagnostic testing, support physician training and reduce reliance on out-of-state laboratories.